Previously, Dr. Takigiku was at Procter & Gamble Pharmaceuticals, and was also interim co-Director of the Genome Research Institute (now the Reading Campus) of the College of Medicine, University of Cincinnati. Dr. Takigiku’s life-long research interests have been in the origin, evolution and sustainability of life. His earliest work focused on elucidating the interplay of the oceans, atmosphere, and early life forms. Later work encompassed toxicology, pharmaceutical discovery and development, and consumer product innovation. Founding Bexion in 2006, the company now has a novel compound in clinical development for solid tumors, including glioblastoma multiforme, a deadly form of brain cancer. Dr. Takigiku received his undergraduate degrees from University of Colorado in Chemistry and Molecular Biology, his PhD in Chemistry from Indiana University, and business training from the Kellogg School of Management.
RSVPs are required to attend, whether you are eating lunch or not, so if you would like to attend please click HERE by 5:00 p.m., Monday, August 30, 2021. Remember to type your FULL NAME when you RSVP, otherwise your RSVP will not come through to be accepted. All guests and prospective members must also RSVP (please have them put your name in parenthesis in their signature).